Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Harvard

Glintborg, B, Sørensen, IJ, Loft, AG, Esbesen, J, Lindegaard, H, Jensen, DV, Danebod, K, Dieperink, SS, Hendricks, O, Hansen, IMJ, Linauskas, A, Kristensen, S, Andersen, LS, Hossein, M, Nordin, H, Andersen, BL, Chrysidis, S, Raun, JL, Manillo, N, Grydehøj, J, Dalgaard, EB, Pedersen, DD, Krogh, NS & Hetland, ML 2017, 'Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry' Annals of the Rheumatic Diseases, bind 76, nr. Suppl 2, s. 553-554.

APA

CBE

Glintborg B, Sørensen IJ, Loft AG, Esbesen J, Lindegaard H, Jensen DV, Danebod K, Dieperink SS, Hendricks O, Hansen IMJ, Linauskas A, Kristensen S, Andersen LS, Hossein M, Nordin H, Andersen BL, Chrysidis S, Raun JL, Manillo N, Grydehøj J, Dalgaard EB, Pedersen DD, Krogh NS, Hetland ML. 2017. Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry. Annals of the Rheumatic Diseases. 76(Suppl 2):553-554.

MLA

Vancouver

Author

Glintborg, Bente ; Sørensen, Inge Juul ; Loft, A. G. ; Esbesen, J. ; Lindegaard, H. ; Jensen, Dorte Vendelbo ; Danebod, K. ; Dieperink, Sabine Sparre ; Hendricks, O. ; Hansen, I. M. J. ; Linauskas, A. ; Kristensen, S. ; Andersen, L. S. ; Hossein, M. ; Nordin, H. ; Andersen, B. L. ; Chrysidis, S. ; Raun, J. L. ; Manillo, N. ; Grydehøj, J. ; Dalgaard, E. B. ; Pedersen, D. D. ; Krogh, N. S. ; Hetland, Merete Lund. / Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry. I: Annals of the Rheumatic Diseases. 2017 ; Bind 76, Nr. Suppl 2. s. 553-554.

Bibtex

@article{921f9b57085346fa83b2d4cb3fd3bfa2,
title = "Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry",
author = "Bente Glintborg and S{\o}rensen, {Inge Juul} and Loft, {A. G.} and J. Esbesen and H. Lindegaard and Jensen, {Dorte Vendelbo} and K. Danebod and Dieperink, {Sabine Sparre} and O. Hendricks and Hansen, {I. M. J.} and A. Linauskas and S. Kristensen and Andersen, {L. S.} and M. Hossein and H. Nordin and Andersen, {B. L.} and S. Chrysidis and Raun, {J. L.} and N. Manillo and J. Grydeh{\o}j and Dalgaard, {E. B.} and Pedersen, {D. D.} and Krogh, {N. S.} and Hetland, {Merete Lund}",
note = "COPECARE",
year = "2017",
language = "English",
volume = "76",
pages = "553--554",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "B M J Group",
number = "Suppl 2",

}

RIS

TY - ABST

T1 - Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry

AU - Glintborg, Bente

AU - Sørensen, Inge Juul

AU - Loft, A. G.

AU - Esbesen, J.

AU - Lindegaard, H.

AU - Jensen, Dorte Vendelbo

AU - Danebod, K.

AU - Dieperink, Sabine Sparre

AU - Hendricks, O.

AU - Hansen, I. M. J.

AU - Linauskas, A.

AU - Kristensen, S.

AU - Andersen, L. S.

AU - Hossein, M.

AU - Nordin, H.

AU - Andersen, B. L.

AU - Chrysidis, S.

AU - Raun, J. L.

AU - Manillo, N.

AU - Grydehøj, J.

AU - Dalgaard, E. B.

AU - Pedersen, D. D.

AU - Krogh, N. S.

AU - Hetland, Merete Lund

N1 - COPECARE

PY - 2017

Y1 - 2017

M3 - Conference abstract in journal

VL - 76

SP - 553

EP - 554

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - Suppl 2

ER -

ID: 52078214